|
Post by bradleysbest on Feb 10, 2015 9:31:54 GMT -5
Spiro that was an awesome video!!!!
|
|
|
Post by biotec on Feb 10, 2015 9:39:42 GMT -5
The guy on the cell phone looks like Biotec. He is probably talking to someone about MNKD. Watch it to the end. safeshare.tv/w/sLtCVDmZnmLOL spiro, That made my morning. I was on the phone with Sierraworld giving some info from PB, She wanted to know more about this trifecta thing.
|
|
|
Post by cusop on Feb 10, 2015 9:40:33 GMT -5
Actually its the opposite they are frightened of the disease and they are dependent upon the medical advice that they receive and in the case of managing the illness if it seems not to be broke don't fix it. This is going to be a generational drug, fit active people are going to want it, which means that they are most likely type 1.
New patients with type 2 will be a massive target for Sanofi .. Once the early adopters start to rave about the drug delivery system then the mass market will slowly adopt.
In my mind it is in MNKD best interest to get the drug into Europe as there is less of an issue with legal setbacks and the population is less inclined to use needles and state managed health care system look for the most cost effective form of thereapy
|
|
|
Post by BlueCat on Feb 10, 2015 10:41:06 GMT -5
If any of you do this trying to spread the word and explain to diabetics the usefulness of afrezza, PLEASE STOP. Im starting to lose count of the number of diabetic forums where an afrezza investor has injected themselves trying to do something good, only to have the diabetic community for whom the thread belongs to rise up against that person. Diabetics don't like/need to be told by someone who has a selfish motive for themselves on what to do. Hell, anyone doesn't like that. I understand that we all want to get the word out and have as many people using aftezza as possible, but leave the diabetic forums for diabetics. They're people just like all of us. They'll figure it out. I certainly haven't posted anywhere. And from a marketing perspective, I do not think this is a case where any publicity is good. I think it is counter-productive. That said, in a similar way that many of the members here have been helping to counter FUD on the stock boards, here's an idea to consider. I am not sure its a good one - curious to hear others thoughts on this ... This group may be able to neutralize the negative impact. What if, when those here encounter a short FUDster posting on the real diabetic boards, or a well-meaning, but misguided investor trying to 'help' - we could very easily create an immediate account. While I don't think non-diabetic or non-medical investors should post on these boards and participate in the medical conversation, perhaps we can post only to do a public-service? Post and clearly identify yourself with something like: "DISCLAIMER: I am an investor. As an investor, I am investing in solutions to help diabetics and their families. People like you.
Some investors are also diabetics or doctors. Unfortunately, some are not. And these non-diabetics participating in boards may have financial motivations. These individuals may be well-intentioned but present information that is misinformed. Or intentionally provide misinformation for personal gain.
The community of investors with hope to help diabetics encourages you to have conversations with your medical providers to find the right solution for your condition. And consider opinions from recognized sources, or those people in your social networks that you have established connections with.
For your convenience, you can find information about Afrezza from the official Sanofi website at www.afrezza.com. "
|
|
|
Post by BlueCat on Feb 10, 2015 10:47:30 GMT -5
I will add that marketing teams in other fields often approach this in a few ways. Not sure what tactic SNY will take, but often there's two camps:
1. Try to control the voice. Do everything they can to remove or prevent any post that reflects their product or solution in negative light. Especially on any board they own or control.
2. Look at the FUD or negative post as an opportunity. Handle the objection constructively and treat it as an opportunity to engage.
If you want to be an evangelist, I highly recommend the latter. But only engage in the medical convo if you have the credentials- and speak from your credentials and identify as thus (e.g. I am a doctor, nurse, diabetic, family member - or as above - well intentioned investor only).
My .02.
|
|
|
Post by babaoriley on Feb 10, 2015 11:05:02 GMT -5
The guy on the cell phone looks like Biotec. He is probably talking to someone about MNKD. Watch it to the end. safeshare.tv/w/sLtCVDmZnmSpiro, that was brilliant, absolutely Faulkneresque, peeling back layers of meaning (as I often have to do with your posts), I finally figured it out. For those who didn't catch it, the message to MannKind fans in that video was "behold the strength of the Bull."
|
|
|
Post by cusop on Feb 10, 2015 11:06:43 GMT -5
Sanofi does not care about Mannkinds share price they are focused on selling there products and they know who to target and they know how to market. A few moaners and daft shorts running around forums trying to troll them is not going to have much impact. In the end its the sales contribution of Sanofi that will determine if the stock will rocket or not.
If and evangelist came to my door I would shut the door
|
|
|
Post by babaoriley on Feb 10, 2015 11:38:22 GMT -5
Actually its the opposite they are frightened of the disease and they are dependent upon the medical advice that they receive and in the case of managing the illness if it seems not to be broke don't fix it. This is going to be a generational drug, fit active people are going to want it, which means that they are most likely type 1. New patients with type 2 will be a massive target for Sanofi .. Once the early adopters start to rave about the drug delivery system then the mass market will slowly adopt. In my mind it is in MNKD best interest to get the drug into Europe as there is less of an issue with legal setbacks and the population is less inclined to use needles and state managed health care system look for the most cost effective form of thereapy Here's how I look at this issue, cusop, I think some of the people that have had the disease for years and years have become very proficient over time in terms of how they handle their use of insulin. I liken it to great craftsmen and artisans, for example, watchmakers, who must loathe digital watches and, to a degree, battery powered watches. Now these people who have admirably and painstakingly become expert in controlling their disease (to the extent possible), see something that is akin to automation, which threatens to dispose of the need for the kind of incredible accuracy these folks have been able to develop and in which they understandably take pride. And I'm sure that many of these "craftsman" type on the diabetic boards are there to teach the wisdom of their ways to others (at some level, not at all unlike stock message boards). I think it would be quite natural for such craftsmen to resist change to something that is akin to a shotgun, as opposed to a rifle.
|
|
|
Post by brentie on Feb 10, 2015 11:40:29 GMT -5
|
|
|
Post by cusop on Feb 10, 2015 12:21:55 GMT -5
Actually its the opposite they are frightened of the disease and they are dependent upon the medical advice that they receive and in the case of managing the illness if it seems not to be broke don't fix it. This is going to be a generational drug, fit active people are going to want it, which means that they are most likely type 1. New patients with type 2 will be a massive target for Sanofi .. Once the early adopters start to rave about the drug delivery system then the mass market will slowly adopt. In my mind it is in MNKD best interest to get the drug into Europe as there is less of an issue with legal setbacks and the population is less inclined to use needles and state managed health care system look for the most cost effective form of thereapy Here's how I look at this issue, cusop, I think some of the people that have had the disease for years and years have become very proficient over time in terms of how they handle their use of insulin. I liken it to great craftsmen and artisans, for example, watchmakers, who must loathe digital watches and, to a degree, battery powered watches. Now these people who have admirably and painstakingly become expert in controlling their disease (to the extent possible), see something that is akin to automation, which threatens to dispose of the need for the kind of incredible accuracy these folks have been able to develop and in which they understandably take pride. And I'm sure that many of these "craftsman" type on the diabetic boards are there to teach the wisdom of their ways to others (at some level, not at all unlike stock message boards). I think it would be quite natural for such craftsmen to resist change to something that is akin to a shotgun, as opposed to a rifle. I agree the few older Diabetics that I have spoken to have will be loath to change they are entering a phase where they want to manage there decease and accept there is no cure. But younger ones I have met have active lives and want to live to the full these are the ones that Afrezza should appeal to. But again this is all a type 1 market
|
|
|
Post by mrmookie123 on Feb 10, 2015 17:56:15 GMT -5
Yea, Sorry about questioning my Pharmacist today about Afrezza while picking up a script.
She never heard of it, she has now !
|
|
|
Post by afrizzle on Feb 10, 2015 19:32:06 GMT -5
A great article by PA, yet again. Interesting debate in in the comments as well.
|
|
|
Post by papihoyos on Feb 14, 2015 8:42:41 GMT -5
link
I am a T2 diabetic and feel an obligation to let people know about Afrezza. I'm also an investor for the past 8 years and as they say in Texas Holdem, I'm ALL IN. See link to a recent win.
|
|
|
Post by cybergym66 on Feb 14, 2015 9:17:53 GMT -5
link
I am a T2 diabetic and feel an obligation to let people know about Afrezza. I'm also an investor for the past 8 years and as they say in Texas Holdem, I'm ALL IN. See link to a recent win. I like to think this is just a small sample of what is going on in other diabetic blogs! The diabetics who have tired Afrezza are nothing but POSITIVE with their experience and those who were on Exubera know it's a no-brainer! After hearing from Afrezzauser (dozens of people telling him they're getting Afrezza) and what I've read on blogs from other diabetics, I think we could see some really good Rx numbers in the next 2-4 weeks (need to give Diabetics time to make appointments and see their Endo).
|
|
|
Post by ezrasfund on Feb 14, 2015 11:44:01 GMT -5
A big issue for diabetics who are skeptical about Afrezza is the dosing question. They are used to calculating dosage to a precise fraction of units and cannot understand why this is not necessary with Afrezza. I think the thread on this board answers those questions, and if someone who is part of the diabetic community could post a precise explanation for them it would be very helpful.
|
|